The Valley Desk

NCT02497469 · Interventional trial

An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis

Overall registry status Completed

Phase 3

Conditions Colitis, Ulcerative

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov